FUTURE OF HEALTHCARE

Medline Announces the Launch of Two Healthcare Sustainability Programs

Medline | December 03, 2020

Medline today announced two new medical care maintainability programs. The projects, a Green Product Portfolio and a Sustainable Packaging Lab, will assist medical clinics with decreasing the measure of product squander emerging from their offices.

As per an ongoing industry report, the United States is the world's most noteworthy producer of medical care greenhouse gases, representing 27% of the worldwide medical care footprint.

"More and more, we are hearing directly from hospitals that they understand the negative consequence their environmental footprint can have on their patient population," said Hannah Anderson, Medline sustainability specialist. "There is a culture change happening to find ways to make their supply chain more sustainable. Being a primary medical supplier partner, we are well positioned to help customers develop meaningful and actionable strategies to improve the health of patients in the communities they serve through sustainability."

Green products portfolio

Medline is introducing a new web page to help make it easier for healthcare providers to find and purchase green products. The company currently has over 40 unique product types that meet Medline's Green Product Portfolio Standards, which are informed by Kaiser Permanente's Environmentally Preferred Purchasing guidelines, the Federal Trade Commission's Green Guides, and the Environmental Protection Agency's guidelines. Hospitals can explore products within three key focus areas:

Environmental services: From wipes to disinfectants, Medline's green options are Green Seal certified and contain fewer chemicals of concern to help minimize the risk of harm to human health and the environment.

Healthcare essentials: Essential products like patient gowns, dinnerware and even plastic cups, are consumed at a rapid rate within healthcare. These green essentials products are designed to incorporate more sustainable materials.

Perioperative care: Operating rooms produce more than 2,000 tons of waste per day. Medline's suite of products including surgical towels, procedural trays and fluid management systems help minimize waste in a cost-effective manner.

Reducing product-packaging waste

The Healthcare Plastics Recycling Council estimates that 2,800 to 3,500 tons of plastic packaging product waste is generated daily by U.S. healthcare facilities. To help reduce material use and waste, Medline is unveiling a Sustainable Packaging Lab, a cross-functional group consisting of employees who specialize in research and development, engineering, packaging and product design. The group will tackle packaging waste from every step of the process and aims to complete and roll out four new projects by the end of 2021.

About Medline

Medline is a healthcare company: a manufacturer, distributor and solutions provider focused on improving the overall operating performance of healthcare. Medline works with both the country's largest healthcare systems and independent facilities across the continuum of care to provide the clinical and supply chain resources required for long-term financial viability in delivering high quality care. With the size of one of the country's largest companies and the agility of a family-owned business, Medline is able to invest in its customers for the long-term and rapidly respond with customized solutions. Headquartered in Northfield, Ill., Medline has 27,000+ employees worldwide, a fleet of nearly 1,000 trucks and does business in more than 90 countries.

Spotlight

Diabetes is an expensive disease, especially when treatment must be intensified. To address this crisis, the World Health Organization (WHO) has released diabetes treatment guidelines that take the cost of drugs into account. They're applicable for disadvantaged groups in the United States.

Spotlight

Diabetes is an expensive disease, especially when treatment must be intensified. To address this crisis, the World Health Organization (WHO) has released diabetes treatment guidelines that take the cost of drugs into account. They're applicable for disadvantaged groups in the United States.

Related News

FUTURE OF HEALTHCARE

RLDatix Completes Acquisition of Allocate Software

RLDatix | September 23, 2021

RLDatix, the international leader in governance, risk and compliance (GRC) solutions for healthcare, announced today the completion of the acquisition of UK-based Allocate Software (“Allocate”), a leading provider of human capital management solutions that help healthcare organisations deliver safe and effective care. The acquisition was previously announced on June 28th, 2021. With the completion of this acquisition, RLDatix cements its position as the global innovator in healthcare GRC, combining its industry leading patient safety, risk, compliance and provider management capabilities with Allocate’s leading workforce management solutions. It also further accelerates Applied Safety IntelligenceTM, the company’s strategy to shift healthcare from reactive risk management to proactive prevention. We’re thrilled to complete the acquisition of Allocate and start the next chapter of our exciting journey together. Covid-19 has reminded us that patient, workforce and organisational safety are inextricably linked, as burnout, well-being of care-givers and overall resilience are challenges felt by healthcare providers around the world. With the acquisition of Allocate, RLDatix is well positioned to continue delivering innovative, scaled and needed solutions that link healthcare GRC and workforce management. Combined, we will make healthcare safer. Jeff Surges, CEO, RLDatix We have always understood the link between patient safety, the welfare of staff and workforce technology and are very excited to join forces with RLDatix. With increasing demand for care and the ongoing clinician shortage being faced in healthcare we fully expect to positively impact both staff welfare and patient outcomes. We will be able to ensure that resources are planned, supported and truly underpinned by patient safety and quality. Nick Wilson, CEO, Allocate Software “The combination of RLDatix and Allocate creates an organisation of significant global scale that is poised to drive innovation in healthcare for years to come,” said Vivek Kumar, Partner at Five Arrows Principal Investments. “We look forward to supporting Jeff and his team in this exciting next phase of the company’s growth.” “RLDatix and Allocate are integral to some of the world’s largest healthcare organisations,” added Reid Perper, CIO, Five Arrows Capital Partners. “This combination is uniquely positioned to deliver continued growth while unlocking exciting new opportunities that will benefit customers around the world.” “It has been a pleasure working with RLDatix over the past three years to scale the business through organic and acquisitive growth, helping to solidify its position as a global leader in GRC,” said Naveen Wadhera, Managing Director at TA. “As we continue our partnership, we believe RLDatix and Allocate’s collective learnings and best practices will strengthen the combined company’s competitive positioning and help healthcare organisations around the world provide safer, higher quality, and more efficient care,” added Ethan Liebermann, Managing Director at TA. Each month, 1.2 million staff utilise Allocate solutions to manage their working lives, over 1.4 million temporary staff shifts are filled and over 8 million hours of nursing care is redeployed for safety-related purposes. Worldwide, millions of people are protected by RLDatix software as they navigate the healthcare system, and as organisations shift towards high reliability, the company’s expanding solution set will provide the data and analytics that drive actionable insights and overall improvement. Together, RLDatix and Allocate will be better able to support strategic initiatives across human capital management, patient & health worker safety, and other healthcare operations critical to driving safer, better care for all. About RLDatix RLDatix is on a mission to change healthcare. We help organisations drive safer, more efficient care by providing governance, risk and compliance tools that drive overall improvement and safety. Our suite of cloud-based software helps organisations report on adverse events, reduce healthcare-acquired infections and ensure patient safety learnings are implemented across the continuum of care. With more than 5,000 customers over 20 countries, RLDatix software protects hundreds of millions of patients around the world. RLDatix is controlled by Five Arrows and TA Associates as major shareholders. For more information, visit www.rldatix.com. About Allocate Software Allocate Software is a leading international provider of Human Capital Management solutions, supporting the operational and administrative needs of health, care, defence and commercial sectors. In the health and care sector, Allocate is enabling the delivery of safe and effective care at optimal cost, by helping organisations to have the right people in the right place at the right time. With over 800 clients and over two million staff rostered daily, Allocate serves the largest public and private sector institutions around the world. Allocate Software is headquartered in the United Kingdom, with nearly 700 employees, including over 200 in research, development, and product management functions. It provides services and support to its international customer base through regional offices in the UK, Sweden, Germany and Australia. For more information, visit www.allocatesoftware.com. About Five Arrows Five Arrows Principal Investments (FAPI) and Five Arrows Capital Partners (FACP), together “Five Arrows”, are part of the corporate private equity arm of Rothschild & Co’s Merchant Banking business which manages over €17 billion. Five Arrows is focused on investing in middle-market companies with highly defensible market positions; strong management teams; business models with high visibility of organic unit volume growth and strong free cash flow conversion; and multiple operational levers that can be used to unlock latent value. Sectors are limited to data and software, technology-enabled business services and healthcare.

Read More

HEALTH TECHNOLOGY

ASUS Aiming an AI-Powered Future in Healthcare

ASUS | April 21, 2021

ASUS, a multinational company known for developing the world's most innovative motherboards, laptops, monitors, and other PC hardware, announced today that cloud-based medical AI services developed by ASUS Intelligent Cloud Services Center (AICS) — ASUS' AI software division — have successfully passed an external audit conducted by SGS Taiwan and obtained ISO 27001:2013 certification for information security. Furthermore, the division passed the Health Insurance Portability and Accountability Act (HIPAA) compliance audit performed by KPMG. Empowering the healthcare industry with AI-powered software innovations AICS developed an EMR search application, a clinical decision support service portal, a drug safety service, and Miraico, an ICD-10 AI coding assistant assisted by cutting-edge Natural Language Understanding (NLU) technology. Miraico will analyze free-text medical records to intelligently understand and instantly prescribe ICD-10 codes. Its user-friendly architecture easily blends with internal workflows, increasing coding efficiency and maximizing hospital reimbursements. These AI services empower healthcare professionals and medical institutions to make data-driven decisions, improve the quality of patient care, and increase overall operational efficiency. The AICS and ASUS Information SecurityCommittee's Information Security Management System (ISMS) seeks to improve processes such as risk assessment, the safe software development life cycle (SSDLC), outsourcing management, and cybersecurity crisis management. The ASUS ISO 27001 certification covers the provision of SaaS-relevant information-security-management activities through AICS, such as application system creation, maintenance, and management, data protection, network communications, and physical security. a business operation certified ISMS can effectively prevent incidents like malware infections, data leaks, and service interruptions, and it represents the continued commitment by ASUS to ensure information security and sustainable corporate operation. The HIPAA-compliant AICS medical AI facilities ensure that no electronic protected health information (ePHI) obtained, distributed, processed, or analyzed without permission can be accessed, disclosed, modified, or destroyed. Pathological samples, medical images, electronic medical records (EMR), anonymized statistical data, and personnel data and system information from hospitals are all examples of ePHI. Healthcare data security, privacy, and availability are secured to the highest degree, and only authorized transfer and access are permitted. About AICS AICS is an ASUS software division with the mission of empowering businesses with powerful AI technology. They develop and implement applications in Precision Healthcare and Industrial Safety using deep innovations in Natural Language Processing, Computer Vision, and Data Analytics, assisting companies in accelerating their transition to an AI-powered future. About ASUS ASUS is a multinational corporation noted for producing the world's best motherboards, PCs, laptops, graphics cards, and routers, and is ranked as the best laptop brand by Laptop Mag in 2020. ASUS leads the industry by cutting-edge architecture and innovations to create the most pervasive, insightful, heartfelt, and enjoyable smart life for all, in addition to an evolving spectrum of superior gaming, content-creation, and AIoT solutions.

Read More

HEALTH TECHNOLOGY

Lightbeam Health Solutions Announces Acquisition of CareSignal, the pioneer of Deviceless Remote Patient Monitoring technology

Lightbeam Health Solutions, Inc | November 16, 2021

Lightbeam Health Solutions, Inc., the leader in end-to-end population health management solutions, announced today the acquisition of CareSignal, the pioneer of Deviceless Remote Patient Monitoring technology. The deal enables Lightbeam to integrate scalable, evidence-based remote engagement and monitoring capabilities into its core population health offering, which serves more than 42 million patient lives across the United States. Together, Lightbeam and CareSignal will deliver best-in-class population-level stratification, actionable real-time insight delivery, and clinical outcome improvement. Current and future industry partners of both companies will benefit from the validated offerings and deep focus on client success. CareSignal brings over 30 condition-specific programs, proven real-world ROI, and a suite of robust AI-based predictive models that complement Lightbeam’s sophisticated population health analytics platform. Combined with the real-time cohort generation capabilities at the core of Lightbeam, CareSignal programs covering chronic conditions, behavioral health, social determinants of health, maternal health, and additional use cases will rapidly generate scalable returns on investment for value-based providers, payers, and self-insured employers. “Lightbeam and CareSignal share a vision for the future of healthcare: care that is proactive, cost-effective, and data-driven. Lightbeam continues to see double-digit year-over-year growth, and CareSignal will help further accelerate our mission to deliver a revolutionary approach to population and risk management.” Lightbeam Founder and CEO, Pat Cline “As part of Lightbeam, I have deep conviction that the CareSignal product and team will achieve the greatest possible impact, delivering clinical and financial value for the patients and healthcare organizations that have the most to gain,” said Blake Marggraff, CareSignal Co-Founder and CEO. “Speaking on behalf of the CareSignal founding team, we are inspired by Lightbeam’s focus on operational excellence, sustainable differentiation, and value creation, along with their deep industry expertise. We are excited to bring our combined businesses to the next level.” About Lightbeam Health Solutions Lightbeam Health Solutions delivers a proven model for managing patient populations and associated risk. Lightbeam’s vision is to bring health data into the light through the use of analytics, and to provide the insight and capabilities healthcare clients need to ensure patients receive the right care at the right time. Lightbeam’s platform facilitates end-to-end population health management for ACOs, payers, provider groups, health systems, and other healthcare organizations aspiring to provide superior care at a lower cost. About CareSignal CareSignal offers Deviceless Remote Patient Monitoring: SMS (text message) and phone-based engagement programs specifically designed for value-based care. The company leverages real-time, self-reported patient data and artificial intelligence to produce long-term patient engagement while identifying clinically actionable moments for proactive care delivery. Proven in 13 peer-reviewed studies and dozens of payer and provider implementations to sustainably scale care teams to manage over ten times more patients, CareSignal drives significant improvements in chronic and behavioral health outcomes, quality measures, and reduced global utilization.

Read More